Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 964 | 1,100 | 2,728 | 17,789 | 39,534 |
| Cost of Goods | 831 | 183 | 190 | 296 | 252 |
| Gross Profit | 133 | 917 | 2,538 | 17,493 | 39,282 |
| Operating Expenses | 32,917 | 32,127 | 30,211 | 57,163 | 32,062 |
| Operating Income | -31,953 | -31,027 | -27,483 | -39,374 | 7,472 |
| Interest Expense | 1,288 | 597 | 494 | 544 | 472 |
| Other Income | 145 | -1,142 | -908 | -1,996 | -2,640 |
| Pre-tax Income | -33,096 | -32,766 | -28,885 | -41,914 | 4,360 |
| Net Income Continuous | -33,096 | -32,766 | -28,885 | -41,914 | 4,360 |
| Minority Interests | -504 | -170 | -288 | -345 | -243 |
| Net Income | $-32,592 | $-32,596 | $-28,597 | $-41,569 | $4,603 |
| EPS Basic Total Ops | -1.90 | -1.90 | -1.60 | -2.86 | 0.30 |
| EPS Basic Continuous Ops | -1.88 | -1.87 | -1.66 | -2.69 | 0.30 |
| EPS Diluted Total Ops | -1.90 | -1.90 | -1.60 | -2.86 | 0.30 |
| EPS Diluted Continuous Ops | -1.88 | -1.87 | -1.66 | -2.68 | 0.30 |
| EBITDA(a) | $-31,708 | $-30,776 | $-27,222 | $-39,149 | $7,731 |